Anika Therapeutics Inc
NASDAQ:ANIK

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
NASDAQ:ANIK
Watchlist
Price: 16.545 USD -2.9% Market Closed
Market Cap: 244.9m USD
Have any thoughts about
Anika Therapeutics Inc?
Write Note

Gross Margin
Anika Therapeutics Inc

48.9%
Current
59%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
48.9%
=
Gross Profit
80.2m
/
Revenue
164.2m

Gross Margin Across Competitors

Country US
Market Cap 244.8m USD
Gross Margin
49%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 300.2B USD
Gross Margin
67%
Country US
Market Cap 158.7B USD
Gross Margin
60%
Country US
Market Cap 126.8B USD
Gross Margin
86%
Country US
Market Cap 115B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 88.3B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34.1B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for Anika Therapeutics Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
48.9%
=
Gross Profit
80.2m
/
Revenue
164.2m
What is the Gross Margin of Anika Therapeutics Inc?

Based on Anika Therapeutics Inc's most recent financial statements, the company has Gross Margin of 48.9%.